0001093557-22-000047.txt : 20220310
0001093557-22-000047.hdr.sgml : 20220310
20220310192421
ACCESSION NUMBER: 0001093557-22-000047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220308
FILED AS OF DATE: 20220310
DATE AS OF CHANGE: 20220310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dolan Matthew Vincent
CENTRAL INDEX KEY: 0001914994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 22730677
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-03-08
0
0001093557
DEXCOM INC
DXCM
0001914994
Dolan Matthew Vincent
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
SVP Corporate Development
Common Stock
2022-03-08
4
A
0
2889
0.001
A
10435
D
Common Stock
2022-03-09
4
D
0
393
406.0567
D
10042
D
Common Stock
2022-03-09
4
D
0
192
406.0567
D
9850
D
Common Stock
2022-03-09
4
D
0
489
406.0567
D
9361
D
Common Stock
2022-03-09
4
D
0
541
406.0567
D
8820
D
Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
Included in this number are 6,634 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
By: Jereme Sylvain For: Matthew V Dolan
2022-03-10